Somatic panel testing reveals no common alternative oncogenic driver in BRCA1/2-mutant high-grade serous ovarian cancer with discordant low genomic instability score.

IF 3.4 2区医学 Q2 GENETICS & HEREDITY

Journal of Medical Genetics Pub Date : 2026-10-08 DOI:10.1136/jmg-2026-111819

Aanum Aanum, Antonio Pereira, Bailey Andrew, Catherine Ramsden, Elizabeth Sollars, Joseph M Shaw, Robert D Morgan, George J Burghel

引用次数: 0

查看原文本刊更多论文

体细胞组检测显示，brca1 /2突变的高级别浆液性卵巢癌中没有共同的替代致癌驱动因素，基因组不稳定性评分不一致。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Medical Genetics 医学-遗传学

CiteScore

7.60

自引率

2.50%

发文量

审稿时长

4-8 weeks

期刊介绍： Journal of Medical Genetics is a leading international peer-reviewed journal covering original research in human genetics, including reviews of and opinion on the latest developments. Articles cover the molecular basis of human disease including germline cancer genetics, clinical manifestations of genetic disorders, applications of molecular genetics to medical practice and the systematic evaluation of such applications worldwide.